Katie Coleman: Looks like I’ve got a bladder polyp? lesion? growth? I named it Newman…
Katie Coleman, Founder of Chromophobe and Oncocytic Tumor Alliance (COA), shared on X/Twitter:
“Looks like I’ve got a bladder polyp? lesion? growth?… I don’t know what we’re calling it at this point. I’ve got a bladder thing that’ll be meeting its eviction day sometime in the near future. When we found the massive tumour on my kidney a couple of years ago, I named it Newman. We landed on Newman after asking for suggestions from my husband and my favourite TV shows.
It was a nice distraction and a good laugh. So, while I try to suppress the past trauma this thing is attempting to resurface, let’s play round two and name this thing. My tumour on my right kidney was very large. This thing is pretty tiny in comparison but in a less-than-ideal location.
My left kidney is named Jerry and my liver is named Kramer. Did we just meet George? I mean George did spend a lot of time sleeping in less than ideal locations (under his desk). Let’s hear your best name suggestions from villains in TV shows or if ya think I should keep the Seinfeld theme going instead and go with George.”
Source: Katie Coleman/Twitter
-
Dec 10, 2023, 17:20 | BlogDaniel Blanco: Day 1 of the 2023 St. Jude Global Alliance Convening
-
Dec 10, 2023, 16:59 | InsightYüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 16:53 | PositiveMatteo Lambertini: December 7, 2023 …a day to remember
-
Dec 10, 2023, 12:45 | BlogSIOP: Worldwide Candle Lighting Day is a celebration of solidarity and memory
-
Dec 10, 2023, 18:12The Cancer Research Interns (CRI) Summer Program is now accepting applications! - Train at NCI
-
Dec 10, 2023, 18:08Apply for the Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities (CRCHD)
-
Dec 10, 2023, 18:01Giselle Sholler: Our research that led to the FDA-Oncologic Drugs Advisory Committee 70% approval for moving Difluoromethylornithine forward
-
Dec 10, 2023, 16:59Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
-
Dec 10, 2023, 12:03Eleonora Teplinsky: The POSITIVE Trial SABCS23 updates are so important to help with oncofertility counseling
-
Dec 10, 2023, 16:53Matteo Lambertini: December 7, 2023 …a day to remember
-
Dec 8, 2023, 16:33Big thank you to Dr. Rucha Kiran Patil for sharing their experiences and learnings on writing abstracts and poster presentations - Novo Nordisk Haemophilia Foundation
-
Dec 6, 2023, 14:57Tracy Gosselin: Jennifer Petruno Receives DAISY Award for Extraordinary Nurses
-
Dec 3, 2023, 16:34Tedros Adhanom Ghebreyesus: Grateful to Namibia’s Prime Minister Saara Kuugongelwa-Amadhila for her commitment to health
-
Dec 2, 2023, 18:08100 Influential Celebrities in Oncology: The 2023 Edition – Part 5
-
Dec 10, 2023, 05:08Global Summit on War and Cancer: Agenda
-
Dec 4, 2023, 16:26SIOP 2023 by Numbers! - International Society of Paediatric Oncology
-
Dec 2, 2023, 16:43In our recent survey, nearly 1,700 ASCO members shared feedback on the ABIM MOC requirements - ASCO
-
Nov 28, 2023, 17:34The International Association of Cancer Registries annual conference - IARC
-
Nov 26, 2023, 18:05Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
Dec 10, 2023, 17:39Dr. Salami is the winner of the American Urological Association’s prestigious Gold Cystoscope Award - YUO
-
Dec 10, 2023, 17:26Mark Awad was honored by GO2 for Lung Cancer at the 18th Annual Simply the Best Gala - Dana-Farber Cancer Institute
-
Dec 9, 2023, 17:00Wafik S. El-Deiry: Honored to share the news of my election as the Chair of the WIN Consortium in Personalized Cancer Medicine
-
Dec 8, 2023, 17:54Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
-
Dec 8, 2023, 17:35Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity